PL2477967T3 - Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process - Google Patents

Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process

Info

Publication number
PL2477967T3
PL2477967T3 PL10760917T PL10760917T PL2477967T3 PL 2477967 T3 PL2477967 T3 PL 2477967T3 PL 10760917 T PL10760917 T PL 10760917T PL 10760917 T PL10760917 T PL 10760917T PL 2477967 T3 PL2477967 T3 PL 2477967T3
Authority
PL
Poland
Prior art keywords
benzodiazepine
imidazo
pyridinyl
bromo
preparing
Prior art date
Application number
PL10760917T
Other languages
Polish (pl)
Inventor
Stuart Gary Tilbrook
Andreas Schumacher
René Emmenegger
Original Assignee
Paion Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paion Uk Ltd filed Critical Paion Uk Ltd
Publication of PL2477967T3 publication Critical patent/PL2477967T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65586Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
PL10760917T 2009-09-18 2010-09-15 Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process PL2477967T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09011914A EP2305647A1 (en) 2009-09-18 2009-09-18 Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
EP10760917.4A EP2477967B1 (en) 2009-09-18 2010-09-15 Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
PCT/EP2010/005668 WO2011032692A1 (en) 2009-09-18 2010-09-15 Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4h-imidazol[1,2-a][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process

Publications (1)

Publication Number Publication Date
PL2477967T3 true PL2477967T3 (en) 2016-04-29

Family

ID=41467237

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10760917T PL2477967T3 (en) 2009-09-18 2010-09-15 Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process

Country Status (18)

Country Link
US (3) US9156842B2 (en)
EP (2) EP2305647A1 (en)
JP (1) JP5801309B2 (en)
KR (1) KR101801735B1 (en)
CN (1) CN102753525B (en)
AU (1) AU2010294873B2 (en)
BR (1) BR112012006053B1 (en)
CA (1) CA2774018C (en)
DK (1) DK2477967T3 (en)
ES (1) ES2555233T3 (en)
HK (1) HK1173437A1 (en)
HR (1) HRP20151316T1 (en)
HU (1) HUE028298T2 (en)
MX (2) MX341093B (en)
PL (1) PL2477967T3 (en)
PT (1) PT2477967E (en)
RU (1) RU2551848C2 (en)
WO (1) WO2011032692A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2081921T3 (en) 2006-07-10 2011-03-31 Paion Uk Ltd Short-acting benzodiazepine salts and their polymorphic forms
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
CN102964349A (en) * 2011-08-31 2013-03-13 江苏恒瑞医药股份有限公司 Tosilate of benzodiazepine derivative, its crystal forms, their preparation method and application
SG11201501358SA (en) 2012-08-31 2015-04-29 Paion Uk Ltd Method for administering hypnotic/sedative agent
AR094963A1 (en) 2013-03-04 2015-09-09 Ono Pharmaceutical Co EXCELLENT OXIDATION REACTION IN THE CONVERSION INDEX
CN103232454A (en) * 2013-05-05 2013-08-07 王元青 Medicine for treating mental disease
CN103230595B (en) * 2013-05-05 2014-10-08 李友香 Composition for treating mental diseases
CN105726495B (en) * 2014-12-12 2019-03-29 宜昌人福药业有限责任公司 A kind of short-acting benzodiazepine salt pharmaceutical composition of injection and preparation method thereof
CN106892924B (en) * 2015-12-17 2021-01-08 四川科伦博泰生物医药股份有限公司 Short-acting benzodiazepine derivatives, method for the production thereof and use thereof
CN107266452A (en) * 2016-04-08 2017-10-20 四川科伦药物研究院有限公司 The salt and its crystal form, preparation method and purposes of benzodiazepine * derivatives
BR112018071082A2 (en) 2016-04-14 2019-02-05 Paion Uk Ltd nasal and orally inhaled benzodiazepines
CN108264499B (en) * 2017-01-04 2020-10-20 江苏恒瑞医药股份有限公司 Preparation method of benzodiazepine derivative
EP3580219B1 (en) 2017-02-09 2022-04-13 Assia Chemical Industries Ltd. Process for the preparation of remimazolam and solid state forms of remimazolam salts
ES2697918A1 (en) * 2017-07-28 2019-01-29 Moehs Iberica Sl PROCEDURE FOR PREPARING METHYL ESTER OF ACID 3 - [(3S) -7-BROMO-2-OXO-5- (PYRIDIN-2-IL) -2,3-DIHYDRO-1H- [1,4] -BENZODIAZEPIN-3- IL] PROPIONIC, AND USEFUL COMPOUNDS IN THAT PROCEDURE (Machine-translation by Google Translate, not legally binding)
ES2709298B2 (en) 2017-10-13 2019-08-21 Moehs Iberica Sl PROCEDURE TO PREPARE METHYL ESTER ACID 3 - [(4S) -8-BROMO-1-METHYL-6- (PIRIDIN-2-IL) -4H-IMIDAZO [1,2-A] [1,4] BENZODIAZEPIN-4 -IL] -PROPIONIC, AND USEFUL COMPOUNDS IN THAT PROCEDURE
CN108033964B (en) * 2017-12-28 2021-02-09 杭州奥默医药股份有限公司 Pyridyl imidazobenzodiazepine propionate compound and synthesis and application thereof
ES2827125A1 (en) * 2019-11-19 2021-05-19 Moehs Iberica Sl USEFUL INTERMEDIATE IN THE PREPARATION OF REMIMAZOLAM, ITS OBTAINING PROCEDURE, AND ITS USE IN THE OBTAINING OF REMIMAZOLAM (Machine-translation by Google Translate, not legally binding)
KR102526590B1 (en) * 2020-06-19 2023-04-28 하나제약 주식회사 METHOD FOR PREPARATION OF 3-[(4S)-8-BROMO-1-METHYL-6-(2-PYRIDINYL)-4H-IMIDAZO[1,2-a][1,4]BENZODIAZEPINE-4-YL]PROPIONIC ACID METHYL ESTER
CN112358483A (en) * 2020-11-09 2021-02-12 中国药科大学 Novel benzodiazepine compound, preparation method and application thereof
CN112321594B (en) * 2020-12-07 2022-05-20 扬子江药业集团有限公司 Preparation method of benzodiazepine medicine
CN114644612B (en) * 2020-12-17 2023-04-28 成都苑东生物制药股份有限公司 Preparation method of benzodiazepine nerve inhibitor intermediate compound
CN113717176B (en) * 2021-10-09 2022-07-05 上海再启生物技术有限公司 Method for preparing remazolam
CN114014839A (en) * 2021-12-16 2022-02-08 上海再启生物技术有限公司 Method for preparing key intermediate of remimazolam
WO2023194945A1 (en) 2022-04-08 2023-10-12 Fresenius Kabi Oncology Ltd. An improved process for the preparation of remimazolam
CN115385891A (en) * 2022-09-06 2022-11-25 上海药坦药物研究开发有限公司 Preparation method of remazolam intermediate

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440959B1 (en) 1999-04-21 2002-08-27 Hoffman-La Roche Inc. Pyrazolobenzodiazepines
GB9911152D0 (en) 1999-05-14 1999-07-14 Glaxo Group Ltd Short-acting benzodiazepines
CA2583536A1 (en) 2004-10-13 2006-04-27 Merck & Co., Inc. Cgrp receptor antagonists
DE602006014097D1 (en) * 2005-01-18 2010-06-17 Merck Sharp & Dohme CGRP RECEPTOR ANTAGONISTS
GB0613692D0 (en) * 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts
PL2081921T3 (en) 2006-07-10 2011-03-31 Paion Uk Ltd Short-acting benzodiazepine salts and their polymorphic forms
GB0613693D0 (en) 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
PL2155712T3 (en) * 2007-05-22 2017-02-28 Chemocentryx, Inc. 3-(imidazolyl)-pyrazolo[3,4-b]pyridines
WO2009145323A1 (en) 2008-05-30 2009-12-03 日産化学工業株式会社 Method for oxidizing alcohol by using polycyclic compound
WO2010043240A1 (en) 2008-10-16 2010-04-22 Paion Uk Limited Administration scheme of polar opioid metabolites for post-operative pain management
WO2010116794A1 (en) 2009-03-30 2010-10-14 日本製紙株式会社 Method for recovery/reuse of n-oxyl compound
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
JP5635275B2 (en) 2010-01-28 2014-12-03 日清紡ホールディングス株式会社 Alcohol oxidation method
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
ES2651389T3 (en) 2012-05-22 2018-01-26 Paion Uk Limited Compositions comprising short-acting benzodiazepines
SG11201501358SA (en) 2012-08-31 2015-04-29 Paion Uk Ltd Method for administering hypnotic/sedative agent
AR094963A1 (en) 2013-03-04 2015-09-09 Ono Pharmaceutical Co EXCELLENT OXIDATION REACTION IN THE CONVERSION INDEX

Also Published As

Publication number Publication date
CA2774018A1 (en) 2011-03-24
DK2477967T3 (en) 2015-12-21
US20120330007A1 (en) 2012-12-27
EP2477967A1 (en) 2012-07-25
BR112012006053B1 (en) 2021-11-16
CN102753525A (en) 2012-10-24
EP2305647A1 (en) 2011-04-06
KR20120102603A (en) 2012-09-18
BR112012006053A2 (en) 2020-11-03
RU2551848C2 (en) 2015-05-27
US20170044135A1 (en) 2017-02-16
HRP20151316T1 (en) 2016-01-15
HUE028298T2 (en) 2016-12-28
AU2010294873B2 (en) 2014-11-13
JP2013505207A (en) 2013-02-14
RU2012115456A (en) 2013-11-10
MX2012003183A (en) 2012-05-08
US9512078B2 (en) 2016-12-06
EP2477967B1 (en) 2015-11-11
US9156842B2 (en) 2015-10-13
MX341093B (en) 2016-08-08
US10000464B2 (en) 2018-06-19
ES2555233T3 (en) 2015-12-29
KR101801735B1 (en) 2017-11-27
MX337683B (en) 2016-03-15
US20150368199A1 (en) 2015-12-24
PT2477967E (en) 2016-01-07
CN102753525B (en) 2015-09-02
HK1173437A1 (en) 2013-05-16
JP5801309B2 (en) 2015-10-28
WO2011032692A1 (en) 2011-03-24
AU2010294873A1 (en) 2012-04-12
CA2774018C (en) 2018-01-30

Similar Documents

Publication Publication Date Title
PT2477967E (en) Process for preparing 3-[(4s)-8-bromo-1-methyl-6-(2-pyridinyl)-4 h-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
IL187302A0 (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
HK1209628A1 (en) Methods, compounds, compositions and vehicles for delivering 3-amino- 1-propanesulfonic acid 3--1-
IL192907A0 (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
IL198970A0 (en) Carboxylic acid derivatives
WO2009089076A3 (en) Processes for the preparation and purification of paliperidone palmitate
IL198330A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
IL198388A0 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
HK1155733A1 (en) Processes for the preparation of 4-oxo-octahydro-indole-1-carbocylic acid methyl ester and derivatives thereof 4----1-
ZA201100428B (en) Imidazo [1,2-a]pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors
HK1166065A1 (en) Process for the preparation of propionic acid derivatives
EG25838A (en) Process for the preparation of amino acid methyl esters
EP2212325A4 (en) 2-arylmethylazetidine-carbapenem-3-carboxylic acid ester derivative or its salt, process for the preparation thereof and pharmaceutical composition comprising the same
HRP20130860T1 (en) Naphthyridine derivative monohydrate and method for producing the same
GB0600712D0 (en) Process for the manufacture of substituted propionic acids
IL184592A0 (en) Process for the preparation of boronic acids and derivatives thereof
EP2042589A4 (en) Process for production of fatty acid alkyl ester, and production system for the process
EP2058294A4 (en) 2-(4-methoxycarbonylmethylphenoxymethyl)benzoic acid methyl ester and method for producing the same
PL2132161T3 (en) Method for the nitration of substituted benzenes in the presence of propionic acid
GB201001081D0 (en) Process for the preparation of risperidone
EP2459550A4 (en) R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial
ZA201205062B (en) Process for the preparation of propionic acid derivatives
EP2216320A4 (en) Novel carboxylic acid ester, use of the same, and method for producing the same
ZA200709777B (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
IL213110A0 (en) Process for the preparation of tetrazine derivatives